N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection

被引:40
作者
Li, Y
Rey-Cuille, MA
Hu, SL
机构
[1] Univ Washington, Washington Reg Primate Res Ctr, Seattle, WA 98121 USA
[2] Univ Washington, Dept Pharmaceut, Seattle, WA 98121 USA
关键词
D O I
10.1089/08892220152644179
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The V3 hypervariable region of HIV-1 surface protein has been identified as a major determinant for viral tropism and coreceptor usage. However, the role of the highly conserved N-linked glycan at the V3 loop remains controversial. To further examine its role in viral infection, we introduced a conservative amino acid substitution (asparagine to glutamine) in the V3-proximal glycosylation motif (Asn-X-Ser/Thr) in the surface glycoprotein of a CXCR4-using virus (BRU), a CCR5-using virus (SF162), and a dual-tropic virus (89.6). The effect of the mutation was determined by complementation assays, and by infectivity on CEMx174 and U373-MAGI cells expressing either CXCR4 or CCR5. The mutation resulted in decreased CXCR4 usage by SHIV89.6, but increased usage by BRU. Similarly, it abrogated CCR5 usage by SHIV89.6, but had no effect on SF162. This effect was not dependent on the specific amino acid substitution used, because a threonine-to-alanine mutation in the same motif in 89.6 Env yielded identical results as the asparagine-to-glutamine mutation. These findings support the notion that multiple factors, including glycosylation at V3, contribute to coreceptor usage and that the particular effects exerted by the N-linked glycan itself appear to be isolate dependent.
引用
收藏
页码:1473 / 1479
页数:7
相关论文
共 47 条
[1]   AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION [J].
BACK, NKT ;
SMIT, L ;
DEJONG, JJ ;
KEULEN, W ;
SCHUTTEN, M ;
GOUDSMIT, J ;
TERSMETTE, M .
VIROLOGY, 1994, 199 (02) :431-438
[2]  
Berger EA, 1998, ADV EXP MED BIOL, V452, P151
[3]   CARBOHYDRATE DETERMINANT NEUAC-GAL-BETA(1-4) OF N-LINKED GLYCANS MODULATES THE ANTIGENIC ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120 [J].
BOLMSTEDT, A ;
OLOFSSON, S ;
SJOGRENJANSSON, E ;
JEANSSON, S ;
SJOBLOM, I ;
AKERBLOM, L ;
HANSEN, JES ;
HU, SL .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :3099-3105
[4]   Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response [J].
Bolmstedt, A ;
Sjolander, S ;
Hansen, JES ;
Akerblom, L ;
Hemming, A ;
Hu, SL ;
Morein, B ;
Olofsson, S .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 12 (03) :213-220
[5]   EFFECTS OF MUTATIONS IN GLYCOSYLATION SITES AND DISULFIDE BONDS ON PROCESSING, CD4-BINDING AND FUSION ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEINS [J].
BOLMSTEDT, A ;
HEMMING, A ;
FLODBY, P ;
BERNTSSON, P ;
TRAVIS, B ;
LIN, JPC ;
LEDBETTER, J ;
TSU, T ;
WIGZELL, H ;
HU, SL ;
OLOFSSON, S .
JOURNAL OF GENERAL VIROLOGY, 1991, 72 :1269-1277
[6]  
Burns D P, 1994, Curr Top Microbiol Immunol, V188, P185
[7]   IDENTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GENE-SEQUENCES INFLUENCING VIRAL ENTRY INTO CD4-POSITIVE HELA-CELLS, T-LEUKEMIA CELLS, AND MACROPHAGES [J].
CHESEBRO, B ;
NISHIO, J ;
PERRYMAN, S ;
CANN, A ;
OBRIEN, W ;
CHEN, ISY ;
WEHRLY, K .
JOURNAL OF VIROLOGY, 1991, 65 (11) :5782-5789
[8]   Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes [J].
Chesebro, B ;
Wehrly, K ;
Nishio, J ;
Perryman, S .
JOURNAL OF VIROLOGY, 1996, 70 (12) :9055-9059
[9]   Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4 [J].
Cho, MW ;
Lee, MK ;
Carney, MC ;
Berson, JF ;
Doms, RW ;
Martin, MA .
JOURNAL OF VIROLOGY, 1998, 72 (03) :2509-2515
[10]   The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection [J].
Cocchi, F ;
DeVico, AL ;
GarzinoDemo, A ;
Cara, A ;
Gallo, RC ;
Lusso, P .
NATURE MEDICINE, 1996, 2 (11) :1244-1247